Loading...
CAR T-cell Therapy for Pancreatic Cancer
Chimeric antigen receptor (CAR) T-cell therapy utilizes genetic engineering to redirect a patient’s own T cells to target cancer cells. The remarkable results in hematological malignancies prompted investigating this approach in solid tumors such as pancreatic cancer. The complex tumor microenvironm...
Na minha lista:
Udgivet i: | J Surg Oncol |
---|---|
Main Authors: | , , , |
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
2017
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5491361/ https://ncbi.nlm.nih.gov/pubmed/28346697 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jso.24627 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|